Sign In
Buy BLU
$14.74
+0 (+0%)
At Close: Sep 27, 2023
BELLUS Health Shares Slide On Public Offering Of Shares In Canada And US
04:54pm, Wednesday, 13'th Jul 2022
BELLUS Health Inc (NASDAQ: BLU) (TSX:BLU) has filed a preliminary prospectus supplement to its amended and restated short form base shelf prospectus dated December 14, 2021, amending and restating
Has Bellus Health (BLU) Outpaced Other Medical Stocks This Year?
10:50am, Monday, 11'th Jul 2022
Here is how Bellus Health (BLU) and Adherex Technologies Inc. (FENC) have performed compared to their sector so far this year.
This Small-Cap Innovator is Flying High
02:42pm, Wednesday, 29'th Jun 2022
We may be turning the page to a new chapter where small-cap stocks re-establish their supremacy.
Here's Why Bellus Health (BLU) is a Great Momentum Stock to Buy
01:06pm, Tuesday, 28'th Jun 2022
Does Bellus Health (BLU) have what it takes to be a top stock pick for momentum investors? Let's find out.
4 Biotech Stocks With Bright Prospects to Buy Amid Recovery
01:33pm, Friday, 10'th Jun 2022
New drug approvals and development of treatments for COVID-19 should maintain momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and pipeline progress position ALKS, GERN, IMC
Are Medical Stocks Lagging Bellus Health (BLU) This Year?
11:17am, Tuesday, 07'th Jun 2022
Here is how Bellus Health (BLU) and Adherex Technologies Inc. (FENC) have performed compared to their sector so far this year.
Merck (MRK) Keytruda Gets EU Nod for Expanded Breast Cancer Use
12:35pm, Wednesday, 25'th May 2022 Zacks Investment Research
The European Commission approves Merck's (MRK) Keytruda for high-risk early-stage TNBC, which expands its eligible patient population.
Is Bellus Health (BLU) Stock Outpacing Its Medical Peers This Year?
01:40pm, Wednesday, 18'th May 2022 Zacks Investment Research
Here is how Bellus Health (BLU) and Adherex Technologies Inc. (FENC) have performed compared to their sector so far this year.
Is Bellus Health (BLU) Stock Outpacing Its Medical Peers This Year?
11:17am, Wednesday, 18'th May 2022
Here is how Bellus Health (BLU) and Adherex Technologies Inc. (FENC) have performed compared to their sector so far this year.
Wall Street Analysts Believe Bellus (BLU) Could Rally 32%: Here's is How to Trade
01:55pm, Tuesday, 17'th May 2022 Zacks Investment Research
The average of price targets set by Wall Street analysts indicates a potential upside of 31.6% in Bellus (BLU). While the effectiveness of this highly sought-after metric is questionable, the positive
Is Bellus Health (BLU) Outperforming Other Medical Stocks This Year?
01:40pm, Monday, 25'th Apr 2022 Zacks Investment Research
Here is how Bellus Health (BLU) and Innoviva (INVA) have performed compared to their sector so far this year.
Is Bellus Health (BLU) Outperforming Other Medical Stocks This Year?
11:18am, Monday, 25'th Apr 2022
Here is how Bellus Health (BLU) and Innoviva (INVA) have performed compared to their sector so far this year.
Sanofi (SNY) Stock Outperforms Industry YTD: What Lies Ahead?
12:23pm, Thursday, 07'th Apr 2022 Zacks Investment Research
Here we discuss some factors that have been driving Sanofi's (SNY) stock and its outlook for the future.
Vertex (VRTX) Stock Rallies 27% in a Year: What Lies Ahead?
11:47am, Wednesday, 06'th Apr 2022 Zacks Investment Research
In 2022, Vertex (VRTX) expects continued revenue growth as there are more than 25,000 patients who are addressable with Vertex's CF therapies.
Alnylam's (ALNY) Vutrisiran NDA Faces Delay in FDA Decision
01:25pm, Tuesday, 05'th Apr 2022 Zacks Investment Research
The FDA needs time to review new information incorporated into Alnylam's (ALNY) vutrisiran NDA related to a new secondary packaging and labeling facility, which has been cited as a reason for the dela
